Edgewell Personal Care (EPC) 10-Q 8 May 24 2024 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Mar. 31, 2024	Apr. 30, 2024
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2024
Document Transition Report	false
Entity File Number	001-15401
Entity Registrant Name	EDGEWELL PERSONAL CARE COMPANY
Entity Incorporation, State or Country Code	MO
Entity Tax Identification Number	43-1863181
Entity Address, Address Line One	6 Research Drive
Entity Address, City or Town	Shelton,
Entity Address, State or Province	CT
Entity Address, Postal Zip Code	06484
City Area Code	(203)
Local Phone Number	944-5500
Title of 12(b) Security	Common Stock, par value $0.01 per share
Trading Symbol	EPC
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		49,554,277
Entity Central Index Key	0001096752
Current Fiscal Year End Date	--09-30
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q2
Amendment Flag	false

Condensed Consolidated Statemen

Condensed Consolidated Statements of Earnings and Comprehensive Income - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Net sales	$ 599.4	$ 598.4	$ 1,088.3	$ 1,067.5
Cost of products sold	341.3	356.1	632.5	635.6
Gross profit	258.1	242.3	455.8	431.9
Selling, general and administrative expense	107.5	105.2	210.8	200.9
Advertising and sales promotion expense	63.1	62.9	111.3	108.8
Research and development expense	14.2	14.4	27.5	27.8
Restructuring charges	3.2	3	10	5.7
Operating income	70.1	56.8	96.2	88.7
Interest expense associated with debt	20.4	20.7	40.2	40.6
Other expense, net	2.7	9.5	3	4.5
Earnings before income taxes	47	26.6	53	43.6
Income tax provision	11	7.2	12.2	11.8
Net earnings	$ 36	$ 19.4	$ 40.8	$ 31.8
Basic net earnings per share	$ 0.72	$ 0.38	$ 0.82	$ 0.62
Diluted net earnings per share	$ 0.72	$ 0.37	$ 0.81	$ 0.61
Condensed Consolidated Statements of Comprehensive Income
Net earnings	$ 36	$ 19.4	$ 40.8	$ 31.8
Other comprehensive (loss) income, net of tax
Foreign currency translation adjustments	(16)	12.1	11	60.1
Pension and postretirement activity, net of tax	(0.5)	4.5	(0.6)	4.3
Deferred gain (loss) on hedging activity, net of tax	2.7	0.2	(0.7)	(8)
Total other comprehensive (loss) income, net of tax	(13.8)	16.8	9.7	56.4
Total comprehensive income	$ 22.2	$ 36.2	$ 50.5	$ 88.2

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Earnings and Comprehensive Income (Parenthetical) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Pension and postretirement activity, tax	$ (0.2)	$ 1.6	$ (0.8)	$ 1.5
Deferred gain on hedging activity, tax	$ 1.3	$ 0.1	$ (0.3)	$ (3.7)
Diluted net earnings per share	$ 0.72	$ 0.37	$ 0.81	$ 0.61

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2024	Sep. 30, 2023
Current assets
Cash and cash equivalents	$ 196.2	$ 216.4
Trade receivables, less allowance for doubtful accounts	130.6	106.2
Inventories	496.4	492.4
Other current assets	171.6	147.4
Total current assets	994.8	962.4
Property, plant and equipment, net	327.5	337.9
Goodwill	1,333.9	1,331.4
Other intangible assets, net	960.4	973.8
Other assets	139.7	135.2
Total assets	3,756.3	3,740.7
Current liabilities
Notes payable	23.6	19.5
Accounts payable	219.7	194.4
Other current liabilities	298.6	309.5
Total current liabilities	541.9	523.4
Long-term debt	1,350.8	1,360.7
Deferred income tax liabilities	136.1	136.4
Other liabilities	176.2	179.7
Liabilities, Total	2,205	2,200.2
Shareholders’ equity
Preferred shares	0	0
Common shares	0.7	0.7
Additional paid-in capital	1,574.3	1,593.8
Retained earnings	1,047.7	1,022.1
Common shares in treasury at cost	(911.1)	(906.1)
Accumulated other comprehensive loss	(160.3)	(170)
Total shareholders’ equity	1,551.3	1,540.5
Total liabilities and shareholders’ equity	$ 3,756.3	$ 3,740.7

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Mar. 31, 2024	Sep. 30, 2023
Statement of Financial Position [Abstract]
Preferred shares, par value (in usd per share)	$ 0.01	$ 0.01
Preferred shares, authorized (in shares)	10,000,000	10,000,000
Preferred shares, issued (in shares)	0	0
Preferred shares, outstanding (in shares)	0	0
Common shares, par value (in usd per share)	$ 0.01	$ 0.01
Common shares, authorized (in shares)	300,000,000	300,000,000
Common shares, issued (in shares)	65,251,989	65,251,989
Common shares, outstanding (in shares)	49,637,846	50,118,789
Treasury Stock, Common, Shares	15,614,143	15,133,200
Accounts Receivable, Allowance for Credit Loss	$ 5.9	$ 5.6

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash Flow from Operating Activities
Net earnings	$ 40.8	$ 31.8
Depreciation and amortization	44.9	45.6
Share-based compensation expense	13.3	13.3
Loss on sale of assets	0.2	1
Deferred compensation payments	(1.4)	(4.7)
Deferred income taxes	(0.6)	(0.9)
Proceeds (payments) for other operating activities	(5)	(19.4)
Other, net	(36.1)	(72)
Net cash provided by operating activities	56.1	1.9
Cash Flow from Investing Activities
Capital expenditures	(18)	(18.8)
Collection of deferred purchase price on accounts receivable sold	0.1	0.8
Payments for (Proceeds from) Other Investing Activities	(1.8)	2
Other, net	1.8	(2)
Net cash used by investing activities	(19.7)	(20)
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	385	413
Cash payments on debt with original maturities greater than 90 days	(396)	(392)
Proceeds from (payments for) debt with original maturities of 90 days or less	3.9	(1.4)
Repurchase of shares	(30.3)	(30)
Dividends to common shareholders	(15.8)	(16.1)
Net financing inflow from the Accounts Receivable Facility	1.4	4.8
Employee shares withheld for taxes	(7)	(8.1)
Proceeds (payments) for other financing activities	(0.6)	0.8
Net cash used by financing activities	(59.4)	(29)
Effect of exchange rate changes on cash	2.8	13.6
Net decrease in cash and cash equivalents	(20.2)	(33.5)
Cash and cash equivalents, beginning of period	216.4	188.7
Cash and cash equivalents, end of period	$ 196.2	$ 155.2

Condensed Consolidated Statem_4

Condensed Consolidated Statement of Changes in Shareholders' Equity Statement - USD ($) $ in Millions	Total	Reclassification out of Accumulated Other Comprehensive Income	Other expense (income), net Reclassification out of Accumulated Other Comprehensive Income	Common shares	Treasury Stock, Common	Additional paid-in capital	Retained earnings	Accumulated other comprehensive loss
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Treasury Stock, Common, Shares					(13,700,000)
Common shares, issued (in shares)				65,200,000
Treasury Stock, Common, Shares					(13,700,000)
Beginning shareholders' equity at Sep. 30, 2022	$ 1,467.1			$ 0.7	$ (860.9)	$ 1,604.3	$ 939.1	$ (216.1)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	12.4						12.4
Foreign currency translation adjustments	48							48
Pension and postretirement activity, net of tax	(0.2)							(0.2)
Deferred gain (loss) on hedging activity, net of tax	(8.2)							(8.2)
Dividends declared to common shareholders	(8)						(8)
Treasury shares repurchased (in usd)	(15)				$ (15)
Treasury shares repurchased (in shares)					(400,000)
Activity under share plans (shares)					400,000
Activity under share plans (in usd)	(1.5)				$ 25
APIC activity under share plans						(26.5)
Ending shareholders' equity at Dec. 31, 2022	1,494.6			0.7	(850.9)	1,577.8	943.5	(176.5)
Beginning shareholders' equity at Sep. 30, 2022	1,467.1			0.7	(860.9)	1,604.3	939.1	(216.1)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	31.8
Foreign currency translation adjustments	60.1
Pension and postretirement activity, net of tax	4.3
Deferred gain (loss) on hedging activity, net of tax	(8)
Ending shareholders' equity at Mar. 31, 2023	1,515.3			$ 0.7	$ (863.6)	1,583.2	954.7	(159.7)
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
OCI Cash flow hedges reclass to earnings, before tax			$ 5.8
Treasury Stock, Common, Shares					(13,700,000)
Common shares, issued (in shares)				65,200,000
Treasury Stock, Common, Shares					(13,700,000)
Beginning shareholders' equity at Dec. 31, 2022	1,494.6			$ 0.7	$ (850.9)	1,577.8	943.5	(176.5)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	19.4						19.4
Foreign currency translation adjustments	12.1							12.1
Pension and postretirement activity, net of tax	4.5							4.5
Deferred gain (loss) on hedging activity, net of tax	0.2							0.2
Dividends declared to common shareholders	(8.2)						(8.2)
Treasury shares repurchased (in usd)	(15)				$ (15)
Treasury shares repurchased (in shares)					(400,000)
Activity under share plans (shares)					0
Activity under share plans (in usd)	7.7				$ 2.3
APIC activity under share plans						5.4
Ending shareholders' equity at Mar. 31, 2023	$ 1,515.3			$ 0.7	$ (863.6)	1,583.2	954.7	(159.7)
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
OCI Cash flow hedges reclass to earnings, before tax		$ 0.8
Treasury Stock, Common, Shares					(14,100,000)
Common shares, issued (in shares)				65,200,000
Treasury Stock, Common, Shares					(14,100,000)
Treasury Stock, Common, Shares	15,133,200				(15,000,000)
Common shares, issued (in shares)	65,251,989			65,200,000
Treasury Stock, Common, Shares	15,133,200				(15,000,000)
Beginning shareholders' equity at Sep. 30, 2023	$ 1,540.5			$ 0.7	$ (906.1)	1,593.8	1,022.1	(170)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	4.8						(4.8)
Foreign currency translation adjustments	27							27
Pension and postretirement activity, net of tax	(0.1)							(0.1)
Deferred gain (loss) on hedging activity, net of tax	(3.4)							(3.4)
Dividends declared to common shareholders	(7.6)						(7.6)
Treasury shares repurchased (in usd)	(15.5)				$ (15.5)
Treasury shares repurchased (in shares)					(400,000)
Activity under share plans (shares)					200,000
Activity under share plans (in usd)	0.1				$ 25
APIC activity under share plans						(24.9)
Ending shareholders' equity at Dec. 31, 2023	1,545.8			0.7	(896.6)	1,568.9	1,019.3	(146.5)
Beginning shareholders' equity at Sep. 30, 2023	1,540.5			0.7	(906.1)	1,593.8	1,022.1	(170)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	40.8
Foreign currency translation adjustments	11
Pension and postretirement activity, net of tax	(0.6)
Deferred gain (loss) on hedging activity, net of tax	$ (0.7)
Treasury shares repurchased (in shares)	(800,000)
Ending shareholders' equity at Mar. 31, 2024	$ 1,551.3			$ 0.7	$ (911.1)	1,574.3	1,047.7	(160.3)
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
OCI Cash flow hedges reclass to earnings, before tax			$ 2.4
Treasury Stock, Common, Shares					(15,200,000)
Common shares, issued (in shares)				65,200,000
Treasury Stock, Common, Shares					(15,200,000)
Beginning shareholders' equity at Dec. 31, 2023	1,545.8			$ 0.7	$ (896.6)	1,568.9	1,019.3	(146.5)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	36						36
Foreign currency translation adjustments	(16)							(16)
Pension and postretirement activity, net of tax	(0.5)							(0.5)
Deferred gain (loss) on hedging activity, net of tax	2.7							2.7
Dividends declared to common shareholders	(7.6)						(7.6)
Treasury shares repurchased (in usd)	(15.4)				$ (15.4)
Treasury shares repurchased (in shares)					(400,000)
Activity under share plans (shares)					0
Activity under share plans (in usd)	6.3				$ 0.9
APIC activity under share plans						5.4
Ending shareholders' equity at Mar. 31, 2024	$ 1,551.3			$ 0.7	$ (911.1)	$ 1,574.3	$ 1,047.7	$ (160.3)
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
OCI Cash flow hedges reclass to earnings, before tax		$ 0.8
Treasury Stock, Common, Shares	15,614,143				(15,600,000)
Common shares, issued (in shares)	65,251,989			65,200,000
Treasury Stock, Common, Shares	15,614,143				(15,600,000)

Background and Basis of Present

Background and Basis of Presentation	6 Months Ended
	Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Background and Basis of Presentation	Background and Basis of Presentation Background Edgewell Personal Care Company and its subsidiaries (collectively, “Edgewell” or the “Company”) is one of the world’s largest manufacturers and marketers of personal care products in the wet shave, sun and skin care, and feminine care categories. With operations in over 20 countries, the Company’s products are widely available in more than 50 countries. The Company conducts its business in the following three segments: • Wet Shave consists of products sold under the Schick®, Wilkinson Sword TM , Edge, Skintimate®, Billie®, Shave Guard and our custom brands group (formerly sold under our Shave Guard and Personna® brands), as well as non-branded products. The Company’s wet shave products include razor handles and refillable blades, disposable shave products, and shaving gels and creams. • Sun and Skin Care consists of Banana Boat® and Hawaiian Tropic® sun care products, Jack Black®, Bulldog® and Cremo® men’s and women’s grooming products, Billie women’s grooming products and Wet Ones® products. • Feminine Care includes tampons, pads and liners sold under the Playtex Gentle Glide® and Sport®, Stayfree®, Carefree®, and o.b.® brands. Basis of Presentation The accompanying unaudited Condensed Consolidated Financial Statements include the accounts of the Company and its controlled subsidiaries and have been prepared in accordance with United States (“U.S.”) generally accepted accounting principles (“GAAP”) under the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”). The preparation of the unaudited Condensed Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses. Actual results may differ materially from those estimates. All intercompany balances and transactions have been eliminated in consolidation and, in the opinion of management, all normal recurring adjustments considered necessary for a fair statement have been included in the interim results reported. The fiscal year-end balance sheet data was derived from audited consolidated financial statements, but do not include all of the annual disclosures required by GAAP; accordingly, these unaudited Condensed Consolidated Financial Statements should be read in conjunction with the Company’s audited annual consolidated financial statements included in its Annual Report on Form 10-K filed with the SEC on November 28, 2023. Certain immaterial prior year amounts have been reclassified to conform with the current year’s presentation. Recently Issued Accounting Pronouncements In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2023-09 Income Taxes (Topic 740): Improvements to Income Tax Disclosures to update income tax disclosure requirements primarily by requiring specific categories and greater disaggregation within the rate reconciliation and disaggregation of income taxes paid by jurisdiction. The amendments in the ASU also remove disclosures related to certain unrecognized tax benefits and deferred taxes. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024. The amendments may be applied prospectively or retrospectively with early adoption is permitted. We are currently assessing the impact of the requirements on our consolidated financial statements and disclosures. In November 2023, the FASB issued ASU No. 2023-07 Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures to expand reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments in the ASU require that a public entity disclose, on an annual and interim basis, significant segment expenses that are regularly provided to an entity's chief operating decision maker (“CODM”), a description of other segment items by reportable segment, and any additional measures of a segment's profit or loss used by the CODM when deciding how to allocate resources. Annual disclosures are required for fiscal years beginning after December 15, 2023. Interim disclosures are required for periods within fiscal years beginning after December 15, 2024. Retrospective application is required for all prior periods presented with early adoption is permitted. We are currently assessing the impact of the requirements on our consolidated financial statements and disclosures.
Supplier Finance Program	Recently Adopted Accounting Pronouncements In September 2022, the FASB issued Accounting Standards Update 2022-04, " Liabilities - Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations " which requires that a buyer in a supplier finance program disclose additional information about the program for financial statement users including a rollforward of those obligations. The Company adopted the standard as of October 1, 2023, except for amendments relating to the rollforward requirement, which is effective for fiscal years beginning after December 15, 2023.

Restructuring Charges

Restructuring Charges	6 Months Ended
	Mar. 31, 2024
Restructuring Charges [Abstract]
Restructuring Charges	Restructuring Charges Operating Model Redesign In fiscal 2024, the Company continues to take actions to strengthen its operating model, simplify the organization’s ways of working and improve manufacturing and supply chain efficiency and productivity. As a result of these actions, the Company expects to incur restructuring and repositioning related charges of approximately $19 in fiscal 2024. The Company has incurred restructuring and related charges as follows: Three Months Ended March 31, Six Months Ended March 31, 2024 2023 2024 2023 Severance and related costs $ 1.1 $ 1.9 $ 5.0 $ 2.8 Asset write-off and accelerated depreciation 0.2 0.2 0.3 0.2 Consulting, project implementation and management, and other exit costs 1.9 1.1 4.7 3.0 Total restructuring and repositioning expenses (1) (2) $ 3.2 $ 3.2 $ 10.0 $ 6.0 (1) Restructuring and repositioning expenses o f $0.2 are included within Cost of products sold for the three and six months ended March 31, 2023. (2) Restructuring and repositioning expenses of nil and $0.1 are included within Selling, general and administrative expense (“SG&A”) for the three and six months ended March 31, 2023, respectively. The following table summarizes the restructuring activities and related accrual for the six months ended March 31, 2024: Utilized October 1, 2023 Charge to Cash March 31, Severance and related costs $ 3.9 $ 5.3 $ (7.1) $ 2.1 Consulting, project implementation and management, and other exit costs 0.7 4.7 (5.4) — Total restructuring activities and related accrual $ 4.6 $ 10.0 $ (12.5) $ 2.1

Income Taxes

Income Taxes	6 Months Ended
	Mar. 31, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes For the three and six months ended March 31, 2024, the Company had income tax expense of $11.0 and $12.2, respectively, on Earnings before income taxes of $47.0 and $53.0, respectively. The effective tax rate for the three and six months ended March 31, 2024 w as 23.4% and 23.0%, respectively. The difference between the federal statutory rate and the effective rate is primarily due to an unfavorable mix of earnings in higher tax rate jurisdictions. For the three and six months ended March 31, 2023, the Company had income tax expense of $7.2 and $11.8 , respectively, on Earnings before income taxes of $26.6 and $43.6, respectively. The effective tax rate for the three and six months ended March 31, 2023 was 27.0% and 26.9%, respectively. The difference between the federal statutory rate and the effective rate was primarily due to an unfavorable mix of earnings in higher tax rate jurisdictions.

Earnings per Share

Earnings per Share	6 Months Ended
	Mar. 31, 2024
Earnings Per Share [Abstract]
Earnings per Share	Earnings per Share Basic earnings per share is based on the weighted-average number of common shares outstanding during the period. Diluted net earnings per share is based on the number of shares used for the basic earnings per share calculation, adjusted for the dilutive effect of share options, restricted share equivalent (“RSE”) and performance restricted share equivalent (“PRSE”) awards. The following is the reconciliation between the number of weighted-average shares used in the basic and diluted net earnings per share calculation: Three Months Ended Six Months Ended 2024 2023 2024 2023 Basic weighted-average shares outstanding 49.8 51.4 50.0 51.5 Effect of dilutive securities: Options, RSE and PRSE awards 0.4 0.6 0.3 0.5 Total dilutive securities 0.4 0.6 0.3 0.5 Diluted weighted-average shares outstanding 50.2 52.0 50.3 52.0 The following weighted-average common shares were excluded from the calculation of diluted net earnings per share because the effect of including these awards was antidilutive. Three Months Ended Six Months Ended 2024 2023 2024 2023 Option awards 1.1 0.8 1.1 1.0 RSE and PRSE awards 0.3 — 0.5 0.2

Goodwill and Intangible Assets

Goodwill and Intangible Assets	3 Months Ended
	Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Goodwill and Intangible Assets The following table sets forth goodwill by segment: Wet Sun and Skin Feminine Total Gross balance as of October 1, 2023 $ 1,140.5 $ 355.9 $ 206.0 $ 1,702.4 Accumulated goodwill impairment (369.0) (2.0) — (371.0) Net balance as of October 1, 2023 $ 771.5 $ 353.9 $ 206.0 $ 1,331.4 Changes in the six months ended March 31, 2024 Cumulative translation adjustment $ 1.9 $ 0.5 $ 0.1 $ 2.5 Gross balance as of March 31, 2024 $ 1,142.4 $ 356.4 $ 206.1 $ 1,704.9 Accumulated goodwill impairment (369.0) (2.0) — (371.0) Net balance as of March 31, 2024 $ 773.4 $ 354.4 $ 206.1 $ 1,333.9 The following table sets forth intangible assets by class: March 31, 2024 September 30, 2023 Carrying Accumulated Net Carrying Accumulated Net Indefinite lived Trade names and brands $ 594.6 $ — $ 594.6 $ 592.9 $ — $ 592.9 Amortizable Trade names and brands $ 339.6 $ 96.1 $ 243.5 $ 339.6 $ 88.1 $ 251.5 Technology and patents 79.6 76.7 2.9 79.4 76.2 3.2 Customer related and other 271.0 151.6 119.4 269.8 143.6 126.2 Amortizable intangible assets 690.2 324.4 365.8 688.8 307.9 380.9 Total intangible assets $ 1,284.8 $ 324.4 $ 960.4 $ 1,281.7 $ 307.9 $ 973.8 Amortization expense was $7.8 and $15.6 for the three and six months ended March 31, 2024, respectively, and $7.7 and $15.4 for the three and six months ended March 31, 2023, respectively. Estimated amortization expense for amortizable intangible assets is as follows: Estimated amortization expense Remainder of fiscal year 2024 $ 15.5 2025 31.1 2026 30.7 2027 30.5 2028 30.4 2029 30.4 Thereafter 197.2 Goodwill and intangible assets deemed to have an indefinite life are not amortized but are instead reviewed annually for impairment or when indicators of a potential impairment are present. The Company’s annual impairment testing date is July 1. An interim impairment analysis may indicate that carrying amounts of goodwill and other intangible assets require adjustment or that remaining useful lives should be revised. The Company determined there were no triggering events requiring an interim impairment analysis during the three and six months ended March 31, 2024.

Supplemental Balance Sheet Info

Supplemental Balance Sheet Information	6 Months Ended
	Mar. 31, 2024
Supplemental Balance Sheet Information [Abstract]
Supplemental Balance Sheet Information	Supplemental Balance Sheet Information March 31, September 30, Inventories Raw materials and supplies $ 87.3 $ 86.3 Work in process 95.8 91.1 Finished products 313.3 315.0 Total inventories $ 496.4 $ 492.4 Other Current Assets Prepaid expenses $ 78.8 $ 72.5 Value added tax receivables 60.2 43.7 Income taxes receivable 18.5 18.9 Other 14.1 12.3 Total other current assets $ 171.6 $ 147.4 Property, Plant and Equipment Land $ 18.6 $ 18.5 Buildings 144.3 142.6 Machinery and equipment 1,118.7 1,105.3 Capitalized software costs 61.6 60.2 Construction in progress 41.4 38.5 Total gross property, plant and equipment 1,384.6 1,365.1 Accumulated depreciation and amortization (1,057.1) (1,027.2) Total property, plant and equipment, net $ 327.5 $ 337.9 Other Current Liabilities Accrued advertising and sales promotion $ 44.7 $ 31.5 Accrued trade allowances 28.3 29.8 Accrued salaries, vacations and incentive compensation 42.8 65.4 Income taxes payable 8.6 11.9 Returns reserve 33.6 53.5 Value added tax payable 26.5 7.0 Accrued interest 25.2 25.0 Other 88.9 85.4 Total other current liabilities $ 298.6 $ 309.5 Other Liabilities Pensions and other retirement benefits $ 60.7 $ 58.2 Other 115.5 121.5 Total other liabilities $ 176.2 $ 179.7

Accounts Receivable Facility

Accounts Receivable Facility	3 Months Ended
	Mar. 31, 2024
Transfers and Servicing [Abstract]
Accounts receivable facility	Accounts Receivable Facilities The Company participates in accounts receivable facility programs both in the United States and Japan. These receivable agreements are between the Company and MUFG Bank, LTD, and the subsidiaries of both parties. Transfers under the accounts receivable repurchase agreements are accounted for as sales of accounts receivables, resulting in the receivables being derecognized from the Condensed Consolidated Balance Sheet. The purchaser assumes the credit risk at the time of sale and has the right at any time to assign, transfer, or participate any of its rights under the purchased receivables to another bank or financial institution. The purchase and sale of receivables under accounts receivable repurchase agreements is intended to be an absolute and irrevocable transfer without recourse by the purchaser to the Company for the creditworthiness of any obligor. The Company has considered its performance obligation to collect and service the receivables sold in the United States and Japan and has determined that the costs associated with such services are not material. The compensation received is considered acceptable servicing compensation and as such, the Company does not recognize a servicing asset or liability. Accounts receivables sold were $316.4 and $532.5 for the three and six months ended March 31, 2024 , respectively, and $315.5 and $527.6 for the three and six months ended March 31, 2023, respectively . The trade receivables sold that remained outstanding as of March 31, 2024 and September 30, 2023 were $119.3 and $82.1, respectively. The net proceeds received were included in both Cash from operating activities and Cash used by investing activities on the Condensed Consolidated Statements of Cash Flows. The difference between the carrying amount of the trade receivables sold and the sum of the cash received is recorded as a loss on sale of receivables in Other expense, net in the Condensed Consolidated Statements of Earnings and Comprehensive Income. The loss on sale of trade receivables was $1.6 and $2.8 for the three and six months ended March 31, 2024, respectively. The loss on sale of trade receivables was $1.5 and $2.4 for the three and six months ended March 31, 2023 , respectively.

Debt

Debt	6 Months Ended
	Mar. 31, 2024
Debt Disclosure [Abstract]
Debt	Debt The detail of long-term debt was as follows: March 31, September 30, Senior notes, fixed interest rate of 5.5%, due 2028 $ 750.0 $ 750.0 Senior notes, fixed interest rate of 4.1%, due 2029 500.0 500.0 U.S. revolving credit facility 111.0 122.0 Total 1,361.0 1,372.0 Less unamortized debt issuance costs and discount (1) 10.2 11.3 Total long-term debt $ 1,350.8 $ 1,360.7 (1) As of March 31, 2024, debt issuance costs were $6.2 and $4.0 related to the Senior Notes due 2028 and the Senior Notes due 2029, respectively. As of September 30, 2023, debt issuance costs were $6.9 and $4.4 related to the Senior Notes due 2028 and the Senior Notes due 2029, respectively. As of March 31, 2024 and September 30, 2023 , the Company also had outstanding short-term notes payable with financial institutions with original maturities of less than 90 days of $23.6 a nd $19.5, respectively, with weighted-average interest rates of 3.8% and 3.9% as of March 31, 2024 and September 30, 2023, respectively. These notes were primarily outstanding international borrowings. U.S. Revolving Credit Facility On April 2, 2024, the Company and certain subsidiaries of the Company entered into a Restatement Agreement (the "Restatement Agreement") with Bank of America, N.A. as administrative agent and collateral agent, and the several lenders from time to time party thereto, which amended the Company’s Credit Agreement, dated as of March 28, 2020 (as previously amended by that certain Amendment No. 1 to Credit Agreement, dated as of February 6, 2023, and as otherwise amended, amended and restated, supplemented or otherwise modified prior to the Restatement Date, the “Credit Agreement”). Pursuant to the Restatement Agreement, all of the $425.0 of revolving facility commitments under the Credit Agreement (the “Existing Revolving Facility Commitments”) were replaced with an equal amount of new revolving facility commitments (the “Replacement Revolving Facility Commitments”) having substantially similar terms as the Existing Revolving Facility Commitments, except that the maturity date of the Replacement Revolving Facility Commitments will be the earlier of (i) April 2, 2029, and (ii) (a) March 2, 2028, if the aggregate outstanding amount of the Company’s 5.500% Senior Notes due 2028 is greater than $150.0 as of such date and (b) December 29, 2028, if the aggregate outstanding amount of the Company’s 4.125% Senior Notes due 2029 is greater than $150.0 of as such date, in each case, subject to certain exceptions.

Retirement Plans

Retirement Plans	6 Months Ended
	Mar. 31, 2024
Retirement Benefits [Abstract]
Retirement Plans	Retirement Plans The Company has several defined benefit pension plans covering employees in the U.S. and certain employees in other countries. The plans provide retirement benefits based on years of service and compensation. The Company also sponsors or participates in several other non-U.S. pension and postretirement arrangements, including various retirement and termination benefit plans, some of which are required by local law or coordinated with government-sponsored plans, which are not significant in the aggregate and, therefore, are not included in the information presented below. The Company’s net periodic pension and postretirement costs for its material plans were as follows: Three Months Ended Six Months Ended 2024 2023 2024 2023 Service cost $ 0.4 $ 0.4 $ 0.9 $ 0.9 Interest cost 5.4 5.4 10.7 10.6 Expected return on plan assets (4.8) (5.5) (9.7) (10.9) Recognized net actuarial loss 0.3 0.4 0.7 0.8 Defined benefit settlement loss — 7.2 — 7.2 Net periodic cost $ 1.3 $ 7.9 $ 2.6 $ 8.6 The service cost component of the net periodic cost associated with the Company’s retirement plans is recorded to Cost of products sold and SG&A on the Condensed Consolidated Statement of Earnings and Comprehensive Income. The remaining net periodic cost is recorded to Other expense, net on the Condensed Consolidated Statement of Earnings and Comprehensive Income. The Company initiated the wind-up of its Canadian defined benefit pension plan (“Canada Plan”) in June 2021. On September 1, 2021, Edgewell Personal Care Canada ULC (“EPC Canada”) as administrator of the Canada Plan, entered into a buy-in annuity purchase agreement (“Buy-in Agreement”) with Brookfield Annuity Company (“Brookfield Annuity”) for certain members of the Canada Plan. On January 25, 2023, the Company received approval by the Financial Services Regulatory Authority of Ontario to wind-up the Canada Plan. Upon regulatory approval of the Canada Plan, EPC Canada proceeded with purchasing annuities for the remaining Canada Plan participants and converting the Buy-in Agreement to a buy-out annuity purchase agreement (“Buy-out Agreement”), which was purchased and funded by the Canada Plan on March 31, 2023. The Company was relieved of its defined benefit pension obligation through its irrevocable commitment under the Buy-out Agreement. As of the settlement date, the Company remeasured its assets and its project benefit obligation associated with the Canada Plan. Upon settlement, the Company derecognized the assets, projected benefit obligation and losses remaining in accumulated other comprehensive loss associated with the Canada Plan. A loss of $7.2 was recorded in Other expense (income), net on the Condensed Consolidated Statement of Earnings and Comprehensive Income for the three and six months ended March 31, 2023.

Equity

Equity	6 Months Ended
	Mar. 31, 2024
Equity [Abstract]
Shareholders' Equity	Shareholders’ Equity Share Repurchases In January 2018, the Company’s Board of Directors (the “Board”) authorized the repurchase of up to 10.0 shares of the Company’s common stock, replacing the previous share repurchase authorization from May 2015. The Company repurchased 0.8 shares of its common stock for $30.3 during the six months ended March 31, 2024. There are 3.8 shares of common stock available for repurchase in the future under the Board’s authorization as of March 31, 2024. Any future share repurchases may be made in the open market, privately negotiated transactions, or otherwise permitted, and in such amounts and at such times as the Company deems appropriate based upon prevailing market conditions, business needs, and other factors. Dividends Dividend activity in the six months ended March 31, 2024 are as follows: Date Declared Record Date Payable Date Amount Per Share August 1, 2023 September 7, 2023 October 4, 2023 $ 0.15 November 2, 2023 December 6, 2023 January 4, 2024 $ 0.15 February 1, 2024 March 7, 2024 April 4, 2024 $ 0.15 On May 8, 2024, the Board declared a quarterly cash dividend of $0.15 per common share for the third fiscal quarter of 2024. The dividend will be payable on July 9, 2024 to shareholders of record as the close of business on June 6, 2024. Dividends declared during the six months ended March 31, 2024 totaled $15.2. Payments made for dividends during the six months ended March 31, 2024 totaled $15.8.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	6 Months Ended
	Mar. 31, 2024
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Accumulated Other Comprehensive Loss	Accumulated Other Comprehensive Loss The following table presents the changes in Accumulated Other Comprehensive (Loss) Income (“AOCI”), net of tax, by component: Foreign Pension and Hedging Total Balance as of October 1, 2023 $ (86.9) $ (86.0) $ 2.9 $ (170.0) Other comprehensive income (loss), net of tax 11.0 (1.2) 0.9 10.7 Reclassifications to earnings — 0.6 (1.6) (1.0) Balance as of March 31, 2024 $ (75.9) $ (86.6) $ 2.2 $ (160.3) Foreign Pension and Hedging Total Balance as of October 1, 2022 $ (131.2) $ (92.6) $ 7.7 $ (216.1) Other comprehensive income (loss), net of tax 60.1 (1.6) (4.0) 54.5 Reclassifications to earnings — 5.9 (4.0) 1.9 Balance as of March 31, 2023 $ (71.1) $ (88.3) $ (0.3) $ (159.7) The following table presents the reclassifications out of AOCI: Three Months Ended Six Months Ended Affected Line Item in the Details of AOCI Components 2024 2023 2024 2023 Gain on cash flow hedges Foreign exchange contracts $ 0.8 $ 0.8 $ 2.4 $ 5.8 Other expense, net Income tax expense 0.3 0.2 0.8 1.8 Income tax provision 0.5 0.6 1.6 4.0 Amortization of defined benefit pension and postretirement items Actuarial losses (1) $ (0.3) $ (0.4) $ (0.7) $ (0.8) Defined benefit settlement loss — (7.2) — (7.2) Other expense, net Income tax (benefit) — (2.0) (0.1) (2.1) Income tax provision (0.3) (5.6) (0.6) (5.9) Total reclassifications for the period $ 0.2 $ (5.0) $ 1.0 $ (1.9) (1) These AOCI components are included in the computation of net periodic cost. See Note 9 of Notes to Condensed Consolidated Financial Statements.

Financial Instruments and Risk

Financial Instruments and Risk Management	6 Months Ended
	Mar. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Financial Instruments and Risk Management	Financial Instruments and Risk Management In the ordinary course of business, the Company may enter into contractual arrangements (also referred to as derivatives) to reduce its exposure to foreign currency. The Company has master netting agreements with all of its counterparties that allow for the settlement of contracts in an asset position with contracts in a liability position in the event of default. The Company manages counterparty risk through the utilization of investment grade commercial banks, diversification of counterparties, and its counterparty netting arrangements. The section below outlines the types of derivatives in place as of March 31, 2024 and September 30, 2023, as well as the Company’s objectives and strategies for holding derivative instruments. Foreign Currency Risk A significant share of the Company’s sales is tied to currencies other than the U.S. dollar, the Company’s reporting currency. As such, a weakening of currencies relative to the U.S. dollar can have an unfavorable impact on reported earnings. Conversely, strengthening of currencies relative to the U.S. dollar can improve reported results. The primary currencies to which the Company is exposed include the euro, the Japanese yen, the British pound, the Canadian dollar, and the Australian dollar. Additionally, the Company’s foreign subsidiaries enter into internal and external transactions that create non-functional currency balance sheet positions at the foreign subsidiary level. These exposures are generally the result of intercompany purchases, intercompany loans and, to a lesser extent, external purchases, and are revalued in the foreign subsidiary’s local currency at the end of each month. Changes in the value of the non-functional currency balance sheet positions in relation to the foreign subsidiary’s local currency results in an exchange gain or loss recorded in Other expense, net in the Condensed Consolidated Statements of Earnings and Comprehensive Income. The primary currency to which the Company’s foreign subsidiaries are exposed is the U.S. dollar. Cash Flow Hedges As of March 31, 2024, the Company maintains a cash flow hedging program related to foreign currency risk. These derivative instruments have a high correlation to the underlying exposure being hedged and have been deemed highly effective by the Company for accounting purposes in offsetting the associated risk. The Company has forward currency contracts to hedge cash flow uncertainty associated with currency fluctuations. These transactions are accounted for as cash flow hedges. The Company had an unrealized pre-tax gain of $3.4 and an unrealized pre-tax gain of $4.4 as of March 31, 2024 and September 30, 2023, respectively, on these forward currency contracts, which are accounted for as cash flow hedges and included in AOCI in the Condensed Consolidated Balance Sheets. Assuming foreign exchange rates versus the U.S. dollar remain at March 31, 2024 levels over the next 12 months, the majority of the pre-tax gain included in AOCI in the Condensed Consolidated Balance Sheets as of March 31, 2024 is expected to be included in Other expense, net in the Condensed Consolidated Statements of Earnings and Comprehensive Income. Contract maturities for these hedges extend into fiscal 2025. As of March 31, 2024, there were 64 open foreign currency contracts with a total notional value of $108.1. Derivatives not Designated as Hedges The Company has foreign currency derivative contracts, which are not designated as cash flow hedges for accounting purposes, to hedge balance sheet exposures. Any gains or losses on these contracts are expected to be offset by exchange gains or losses on the underlying exposures and, thus, are not expected to be subject to significant market risk. The change in the estimated fair value of the foreign currency contracts for the three and six months ended March 31, 2024, resulted in a gain of $ 1.7 0.6 2.4 0.3 The following table provides estimated fair values of derivative instruments: Fair Value of Assets (Liabilities) as of (1) March 31, September 30, Derivatives designated as cash flow hedging relationships: Foreign currency contracts $ 3.4 $ 4.4 Derivatives not designated as cash flow hedging relationships: Foreign currency contracts $ 0.1 $ 0.9 (1) Derivative assets are presented in Other current assets or Other assets. Derivative liabilities are presented in Other current liabilities or Other liabilities. The following table provides the pre-tax amounts of gains and losses on derivative instruments: Three Months Ended Six Months Ended 2024 2023 2024 2023 Derivatives designated as cash flow hedging relationships: Foreign currency contracts Gain (loss) recognized in OCI (1) $ 4.8 $ 1.3 $ 1.5 $ (5.8) Gain reclassified from AOCI into income (1) (2) 0.8 0.9 2.4 5.8 Derivatives not designated as cash flow hedging relationships: Foreign currency contracts Gain (loss) recognized in income (2) $ 1.7 $ 2.4 $ 0.6 $ (0.3) (1) Each of these derivative instruments had a high correlation to the underlying exposure being hedged for the periods indicated and have been deemed highly effective by the Company in offsetting associated risk. (2) Gain (loss) was recorded in Other expense, net in the Condensed Consolidated Statements of Earnings and Comprehensive Income. The following table provides financial assets and liabilities for balance sheet offsetting: As of March 31, 2024 As of September 30, 2023 Assets (1) Liabilities (2) Assets (1) Liabilities (2) Foreign currency contracts Gross amounts of recognized assets (liabilities) $ 3.6 $ (1.2) $ 6.1 $ (0.7) Gross amounts offset in the balance sheet (0.2) — (0.2) 0.4 Net amounts of assets (liabilities) presented in the balance sheet $ 3.4 $ (1.2) $ 5.9 $ (0.3) (1) All derivative assets are presented in Other current assets or Other assets on the Condensed Consolidated Balance Sheets. (2) All derivative liabilities are presented in Other current liabilities or Other liabilities on the Condensed Consolidated Balance Sheets. Fair Value Hierarchy Accounting guidance on fair value measurements for certain financial assets and liabilities requires that assets and liabilities carried at fair value be classified in one of the following three categories: Level 1: Quoted market prices in active markets for identical assets or liabilities. Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data. Level 3: Unobservable inputs reflecting the reporting entity’s own assumptions or external inputs from inactive markets. The following table sets forth the Company’s financial assets and liabilities, which are carried at fair value and measured on a recurring basis during the period, all of which are classified as Level 2 within the fair value hierarchy: March 31, September 30, Assets (Liabilities) at estimated fair value: Deferred compensation liability $ (20.5) $ (19.4) Derivatives - foreign currency contracts asset 2.2 5.6 Net assets (liabilities) at estimated fair value $ (18.3) $ (13.8) The estimated fair value of the deferred compensation liability is determined based upon the quoted market prices of the investment options that are offered under the plan. As of March 31, 2024 and September 30, 2023, the estimated fair value of foreign currency contracts is the amount that the Company would receive or pay to terminate the contracts, considering first the quoted market prices of comparable agreements or, in the absence of quoted market prices, factors such as interest rates, currency exchange rates, and remaining maturities. As of March 31, 2024 and September 30, 2023, the Company had no Level 1 financial assets or liabilities, other than pension plan assets, and no Level 3 financial assets or liabilities as of March 31, 2024 and September 30, 2023, respectively. As of March 31, 2024 and September 30, 2023, the fair market value of fixed rate long-term debt was $1,127.9 and $1,028.6, respectively, compared to its carrying value of $1,250.0 in each period. The estimated fair value of the long-term debt was estimated using yields obtained from independent pricing sources for similar types of borrowing arrangements. The estimated fair value of long-term debt, excluding the Company’s credit agreement, dated as of March 28, 2020, by and among, inter alia, the Company, the subsidiaries of the Company from time to time parties thereto, the lenders from time to time parties thereto, MUFG, as syndication agent, TD as joint lead arranger and BofA, as administrative agent and collateral agent (the "Revolving Credit Facility"), has been determined based on Level 2 inputs.

Segment Data

Segment Data	6 Months Ended
	Mar. 31, 2024
Segment Reporting [Abstract]
Segment Data	Segment Data For an overview of the Company’s segments, refer to Note 1 of the Notes to Condensed Consolidated Financial Statements. Segment performance is evaluated based on segment profit, excluding certain U.S. GAAP items that management does not believe are indicative of ongoing operating performance due to their unusual or non-recurring nature and which may have a disproportionate positive or negative impact on the Company’s financial results in any particular period. Financial items, such as interest income and expense, are managed on a global basis at the corporate level and therefore are excluded from segment profit. The exclusion of such charges from segment results reflects management’s view on how management monitors and evaluates segment operating performance, generates future operating plans and makes strategic decisions regarding the allocation of capital. The Company’s operating model includes some shared business functions across the segments, including product warehousing and distribution, transaction processing functions and, in most cases, combined sales force and management teams. The Company applies a fully allocated cost basis in which shared business functions are allocated between the segments. Segment net sales and profitability are presented below: Three Months Ended Six Months Ended 2024 2023 2024 2023 Net Sales Wet Shave $ 293.1 $ 308.6 $ 594.8 $ 583.9 Sun and Skin Care 235.8 209.7 351.2 322.6 Feminine Care 70.5 80.1 142.3 161.0 Total net sales $ 599.4 $ 598.4 $ 1,088.3 $ 1,067.5 Segment Profit Wet Shave $ 40.4 $ 35.4 $ 94.1 $ 71.1 Sun and Skin Care 54.4 40.0 53.1 53.3 Feminine Care 8.7 12.2 16.0 24.1 Total segment profit 103.5 87.6 163.2 148.5 General corporate and other expenses (15.0) (17.0) (31.2) (32.9) Amortization of intangibles (7.8) (7.7) (15.6) (15.4) Interest and other expense, net (23.1) (23.0) (43.2) (37.9) Restructuring and repositioning expenses (1) (3.2) (3.0) (10.0) (5.8) Acquisition and integration costs (2) (0.7) (2.0) (1.4) (4.1) Sun Care reformulation costs (3) (0.4) (0.6) (0.9) (1.1) Wet Ones manufacturing plant fire (4) (3.8) — (5.3) — Legal matter (5) (1.4) — (1.4) — Defined benefit settlement loss (6) — (7.2) — (7.2) Other project costs (7) (1.1) (0.5) (1.2) (0.5) Total earnings before income taxes $ 47.0 $ 26.6 $ 53.0 $ 43.6 (1) Includes pre-tax SG&A of nil and $0.1 for the three and six months ended March 31, 2023, respectively. Includes pre-tax Cost of products sold of $0.2 for the three and six months ended March 31, 2023, respectively. There were no amounts for pre-tax SG&A nor pre-tax Cost of products sold for the three and six months ended March 31, 2024. See Note 2 of the Notes to Condensed Consolidated Financial Statements. (2) Includes pre-tax SG&A of $0.7 and $1.4 for the three and six months ended March 31, 2024, respectively, for the acquisition of Billie, Inc. on November 29, 2021. Includes pre-tax SG&A of $2.0 and $4.1 for the three and six months ended March 31, 2023, respectively. (3) Includes pre-tax research and development costs of $0.4 and 0.9 for the three and six months ended March 31, 2024, respectively, and $0.6 and $1.1 for the three and six months ended March 31, 2023, respectively, related to the reformulation, recall and destruction of certain Sun Care products. (4) On December 1, 2023, a fire occurred at our Wet Ones manufacturing plant in Sidney, Ohio. There were no injuries reported and damage was limited to a single manufacturing process. As a consequence of the fire damage, there was a partial shutdown of the operations that manufacture Wet Ones raw materials. Through the three and six months ended March 31, 2024, the Company has incurred $3.8 and $5.3, respectively, in costs related to incremental material charges, labor and absorption as a result of the fire. (5) Includes pre-tax SG&A of $1.4 for both the three and six months ended March 31, 2024 related to the reserve for a legal matter. (6) Includes pre-tax loss of $7.2 for the three and six months ended March 31, 2023 related to the settlement of the Canada Plan. See Note 9 of the Notes to Condensed Consolidated Financial Statements. (7) Includes pre-tax SG&A of $1.1 and $1.2 for the three and six months ended March 31, 2024 and $0.5 and $0.5 for the three and six months ended March 31, 2023 related to certain corporate project costs. The following table presents the Company’s net sales by geographic area: Three Months Ended Six Months Ended 2024 2023 2024 2023 Net Sales to Customers United States $ 355.1 $ 367.9 $ 609.3 $ 639.7 International 244.3 230.5 479.0 427.8 Total net sales $ 599.4 $ 598.4 $ 1,088.3 $ 1,067.5 Supplemental product information is presented below for net sales: Three Months Ended Six Months Ended 2024 2023 2024 2023 Razors and blades $ 264.8 $ 278.4 $ 535.3 $ 525.4 Tampons, pads, and liners 70.5 80.1 142.3 161.0 Sun care products 175.0 153.8 226.0 201.6 Grooming products 45.0 38.0 91.8 85.3 Wipes and other skin care 15.8 17.9 33.4 35.7 Shaving gels and creams 28.3 30.2 59.5 58.5 Total net sales $ 599.4 $ 598.4 $ 1,088.3 $ 1,067.5

Commitment and Contingencies

Commitment and Contingencies	3 Months Ended
	Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure	Commitments and Contingencies Legal Proceedings The Company and its subsidiaries are subject to a number of legal proceedings in various jurisdictions arising out of its operations during the ordinary course of business. Many of these legal matters are in preliminary stages and involve complex issues of law and fact and may proceed for protracted periods of time. The amount of liability, if any, from these proceedings cannot be determined with certainty. The Company reviews its legal proceedings and claims, regulatory reviews and inspections and other legal proceedings on an ongoing basis and follows appropriate accounting guidance when making accrual and disclosure decisions. The Company establishes accruals for those contingencies when the incurrence of a loss is probable and can be reasonably estimated and discloses the amount accrued and the amount of a reasonably possible loss in excess of the amount accrued if such disclosure is necessary for its financial statements to not be misleading. The Company does not record liabilities when the likelihood that the liability has been incurred is probable, but the amount cannot be reasonably estimated. Based upon present information, the Company believes that its liability, if any, arising from such pending legal proceedings, asserted legal claims, and known potential legal claims which are likely to be asserted, is not reasonably likely to be material to its financial position, results of operations or cash flows, when taking into account established accruals for estimated liabilities.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended				6 Months Ended
	Mar. 31, 2024	Dec. 31, 2023	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2024	Mar. 31, 2023
Pay vs Performance Disclosure
Net earnings	$ 36	$ 4.8	$ 19.4	$ 12.4	$ 40.8	$ 31.8

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Mar. 31, 2024
Trading Arrangements, by Individual
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false

Organization, Consolidation and

Organization, Consolidation and Presentation of Financial Statements (Policies)	6 Months Ended
	Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Business Description and Basis of Presentation	Edgewell Personal Care Company and its subsidiaries (collectively, “Edgewell” or the “Company”) is one of the world’s largest manufacturers and marketers of personal care products in the wet shave, sun and skin care, and feminine care categories. With operations in over 20 countries, the Company’s products are widely available in more than 50 countries. The Company conducts its business in the following three segments: • Wet Shave consists of products sold under the Schick®, Wilkinson Sword TM , Edge, Skintimate®, Billie®, Shave Guard and our custom brands group (formerly sold under our Shave Guard and Personna® brands), as well as non-branded products. The Company’s wet shave products include razor handles and refillable blades, disposable shave products, and shaving gels and creams. • Sun and Skin Care consists of Banana Boat® and Hawaiian Tropic® sun care products, Jack Black®, Bulldog® and Cremo® men’s and women’s grooming products, Billie women’s grooming products and Wet Ones® products. • Feminine Care includes tampons, pads and liners sold under the Playtex Gentle Glide® and Sport®, Stayfree®, Carefree®, and o.b.® brands.
Basis of Accounting, Policy	Basis of Presentation The accompanying unaudited Condensed Consolidated Financial Statements include the accounts of the Company and its controlled subsidiaries and have been prepared in accordance with United States (“U.S.”) generally accepted accounting principles (“GAAP”) under the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”). The preparation of the unaudited Condensed Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses. Actual results may differ materially from those estimates. All intercompany balances and transactions have been eliminated in consolidation and, in the opinion of management, all normal recurring adjustments considered necessary for a fair statement have been included in the interim results reported. The fiscal year-end balance sheet data was derived from audited consolidated financial statements, but do not include all of the annual disclosures required by GAAP; accordingly, these unaudited Condensed Consolidated Financial Statements should be read in conjunction with the Company’s audited annual consolidated financial statements included in its Annual Report on Form 10-K filed with the SEC on November 28, 2023. Certain immaterial prior year amounts have been reclassified to conform with the current year’s presentation. Recently Issued Accounting Pronouncements In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2023-09 Income Taxes (Topic 740): Improvements to Income Tax Disclosures to update income tax disclosure requirements primarily by requiring specific categories and greater disaggregation within the rate reconciliation and disaggregation of income taxes paid by jurisdiction. The amendments in the ASU also remove disclosures related to certain unrecognized tax benefits and deferred taxes. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024. The amendments may be applied prospectively or retrospectively with early adoption is permitted. We are currently assessing the impact of the requirements on our consolidated financial statements and disclosures. In November 2023, the FASB issued ASU No. 2023-07 Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures to expand reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments in the ASU require that a public entity disclose, on an annual and interim basis, significant segment expenses that are regularly provided to an entity's chief operating decision maker (“CODM”), a description of other segment items by reportable segment, and any additional measures of a segment's profit or loss used by the CODM when deciding how to allocate resources. Annual disclosures are required for fiscal years beginning after December 15, 2023. Interim disclosures are required for periods within fiscal years beginning after December 15, 2024. Retrospective application is required for all prior periods presented with early adoption is permitted. We are currently assessing the impact of the requirements on our consolidated financial statements and disclosures. Recently Adopted Accounting Pronouncements In September 2022, the FASB issued Accounting Standards Update 2022-04, " Liabilities - Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations " which requires that a buyer in a supplier finance program disclose additional information about the program for financial statement users including a rollforward of those obligations. The Company adopted the standard as of October 1, 2023, except for amendments relating to the rollforward requirement, which is effective for fiscal years beginning after December 15, 2023.
Comparability of Prior Year Financial Data, Policy	Revision of Previously Issued Consolidated Financial Statements As previously disclosed in the Company’s 2023 Annual Report on Form 10-K filed with the SEC on November 28, 2023, the Company evaluated aged accrued expenditures related to goods received but not yet invoiced by certain of its vendors (“GRNI”). Based upon an assessment, including evaluating the expiry of the applicable statute of limitations of the accrued expenditures, the Company concluded that $8.5 of aged accrued GRNI originating in years 2014 through 2018 were no longer required to be reflected as accounts payable on the Consolidated Balance Sheet as of September 30, 2023 and should have been reversed in prior fiscal years. The Company concluded that the misstatements were not material, either individually or in the aggregate, to its previously issued consolidated financial statements. To correct the immaterial misstatements, the Company has revised the Condensed Consolidated Statements of Earnings and Comprehensive Income and Condensed Consolidated Statements of Changes in Shareholders' Equity for the three and six months ended March 31, 2023, the Condensed Consolidated Statements of Cash Flows for the six months ended March 31, 2023, as well as the associated Notes to the Condensed Consolidated Financial Statements to reflect the corrections of these immaterial misstatements as of and for the three and six months ended March 31, 2023. There were no changes to previously issued total cash flows generated from (used by) operating, investing, or financing activities for six months ended March 31, 2023. The following table reflects the revisions to the previously issued Condensed Consolidated Statements of Earnings and Comprehensive Income for the three and six months ended March 31, 2023: Three Months Ended March 31, 2023 Six Months Ended March 31, 2023 As Previously Reported Adjustment As Revised As Previously Reported Adjustment As Revised Cost of products sold $ 356.7 $ (0.6) $ 356.1 $ 636.8 $ (1.2) $ 635.6 Gross profit 241.7 0.6 242.3 430.7 1.2 431.9 Operating income 56.2 0.6 56.8 87.5 1.2 88.7 Earnings before income taxes 26.0 0.6 26.6 42.4 1.2 43.6 Income tax provision 7.0 0.2 7.2 11.5 0.3 11.8 Net earnings 19.0 0.4 19.4 30.9 0.9 31.8 Earnings per share: Basic net earnings per share $ 0.37 $ 0.01 $ 0.38 $ 0.60 $ 0.02 $ 0.62 Dilutive net earnings per share 0.37 — 0.37 0.60 0.01 0.61 Total comprehensive income 35.8 0.4 36.2 87.3 0.9 88.2 The following table reflects the revisions to the previously issued Condensed Consolidated Statements of Cash Flows for the six months ended March 31, 2023. As Previously Reported Adjustment As Revised Net earnings $ 30.9 $ 0.9 $ 31.8 Changes in operating assets and liabilities (71.1) (0.9) (72.0)

Restructuring Charges (Tables)

Restructuring Charges (Tables)	6 Months Ended
	Mar. 31, 2024
Restructuring Charges [Abstract]
Schedule of Charges Related to Restructuring Activities	Three Months Ended March 31, Six Months Ended March 31, 2024 2023 2024 2023 Severance and related costs $ 1.1 $ 1.9 $ 5.0 $ 2.8 Asset write-off and accelerated depreciation 0.2 0.2 0.3 0.2 Consulting, project implementation and management, and other exit costs 1.9 1.1 4.7 3.0 Total restructuring and repositioning expenses (1) (2) $ 3.2 $ 3.2 $ 10.0 $ 6.0 (1) Restructuring and repositioning expenses o f $0.2 are included within Cost of products sold for the three and six months ended March 31, 2023. (2) Restructuring and repositioning expenses of nil and $0.1 are included

Earnings per Share (Tables)

Earnings per Share (Tables)	6 Months Ended
	Mar. 31, 2024
Earnings Per Share [Abstract]
Schedule of Weighted-Average Shares Outstanding	The following is the reconciliation between the number of weighted-average shares used in the basic and diluted net earnings per share calculation: Three Months Ended Six Months Ended 2024 2023 2024 2023 Basic weighted-average shares outstanding 49.8 51.4 50.0 51.5 Effect of dilutive securities: Options, RSE and PRSE awards 0.4 0.6 0.3 0.5 Total dilutive securities 0.4 0.6 0.3 0.5 Diluted weighted-average shares outstanding 50.2 52.0 50.3 52.0
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The following weighted-average common shares were excluded from the calculation of diluted net earnings per share because the effect of including these awards was antidilutive. Three Months Ended Six Months Ended 2024 2023 2024 2023 Option awards 1.1 0.8 1.1 1.0 RSE and PRSE awards 0.3 — 0.5 0.2

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	6 Months Ended
	Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The following table sets forth intangible assets by class: March 31, 2024 September 30, 2023 Carrying Accumulated Net Carrying Accumulated Net Indefinite lived Trade names and brands $ 594.6 $ — $ 594.6 $ 592.9 $ — $ 592.9 Amortizable Trade names and brands $ 339.6 $ 96.1 $ 243.5 $ 339.6 $ 88.1 $ 251.5 Technology and patents 79.6 76.7 2.9 79.4 76.2 3.2 Customer related and other 271.0 151.6 119.4 269.8 143.6 126.2 Amortizable intangible assets 690.2 324.4 365.8 688.8 307.9 380.9 Total intangible assets $ 1,284.8 $ 324.4 $ 960.4 $ 1,281.7 $ 307.9 $ 973.8
Schedule of Amortizable Intangible Assets	The following table sets forth intangible assets by class: March 31, 2024 September 30, 2023 Carrying Accumulated Net Carrying Accumulated Net Indefinite lived Trade names and brands $ 594.6 $ — $ 594.6 $ 592.9 $ — $ 592.9 Amortizable Trade names and brands $ 339.6 $ 96.1 $ 243.5 $ 339.6 $ 88.1 $ 251.5 Technology and patents 79.6 76.7 2.9 79.4 76.2 3.2 Customer related and other 271.0 151.6 119.4 269.8 143.6 126.2 Amortizable intangible assets 690.2 324.4 365.8 688.8 307.9 380.9 Total intangible assets $ 1,284.8 $ 324.4 $ 960.4 $ 1,281.7 $ 307.9 $ 973.8 Amortization expense was $7.8 and $15.6 for the three and six months ended March 31, 2024, respectively, and $7.7 and $15.4 for the three and six months ended March 31, 2023, respectively. Estimated amortization expense for amortizable intangible assets is as follows: Estimated amortization expense Remainder of fiscal year 2024 $ 15.5 2025 31.1 2026 30.7 2027 30.5 2028 30.4 2029 30.4 Thereafter 197.2

Supplemental Balance Sheet In_2

Supplemental Balance Sheet Information (Tables)	6 Months Ended
	Mar. 31, 2024
Supplemental Balance Sheet Information [Abstract]
Supplement Balance Sheet Information	March 31, September 30, Inventories Raw materials and supplies $ 87.3 $ 86.3 Work in process 95.8 91.1 Finished products 313.3 315.0 Total inventories $ 496.4 $ 492.4 Other Current Assets Prepaid expenses $ 78.8 $ 72.5 Value added tax receivables 60.2 43.7 Income taxes receivable 18.5 18.9 Other 14.1 12.3 Total other current assets $ 171.6 $ 147.4 Property, Plant and Equipment Land $ 18.6 $ 18.5 Buildings 144.3 142.6 Machinery and equipment 1,118.7 1,105.3 Capitalized software costs 61.6 60.2 Construction in progress 41.4 38.5 Total gross property, plant and equipment 1,384.6 1,365.1 Accumulated depreciation and amortization (1,057.1) (1,027.2) Total property, plant and equipment, net $ 327.5 $ 337.9 Other Current Liabilities Accrued advertising and sales promotion $ 44.7 $ 31.5 Accrued trade allowances 28.3 29.8 Accrued salaries, vacations and incentive compensation 42.8 65.4 Income taxes payable 8.6 11.9 Returns reserve 33.6 53.5 Value added tax payable 26.5 7.0 Accrued interest 25.2 25.0 Other 88.9 85.4 Total other current liabilities $ 298.6 $ 309.5 Other Liabilities Pensions and other retirement benefits $ 60.7 $ 58.2 Other 115.5 121.5 Total other liabilities $ 176.2 $ 179.7

Debt (Tables)

Debt (Tables)	6 Months Ended
	Mar. 31, 2024
Debt Disclosure [Abstract]
Schedule of Long-term Debt	The detail of long-term debt was as follows: March 31, September 30, Senior notes, fixed interest rate of 5.5%, due 2028 $ 750.0 $ 750.0 Senior notes, fixed interest rate of 4.1%, due 2029 500.0 500.0 U.S. revolving credit facility 111.0 122.0 Total 1,361.0 1,372.0 Less unamortized debt issuance costs and discount (1) 10.2 11.3 Total long-term debt $ 1,350.8 $ 1,360.7 (1) As of March 31, 2024, debt issuance costs were $6.2 and $4.0 related to the Senior Notes due 2028 and the Senior Notes due 2029, respectively. As of September 30, 2023, debt issuance costs were $6.9 and $4.4 related to the Senior Notes due 2028 and the Senior Notes due 2029, respectively.

Retirement Plans (Tables)

Retirement Plans (Tables)	6 Months Ended
	Mar. 31, 2024
Retirement Benefits [Abstract]
Schedule of Net Periodic Pension and Postretirement Cost (Benefit)	The Company’s net periodic pension and postretirement costs for its material plans were as follows: Three Months Ended Six Months Ended 2024 2023 2024 2023 Service cost $ 0.4 $ 0.4 $ 0.9 $ 0.9 Interest cost 5.4 5.4 10.7 10.6 Expected return on plan assets (4.8) (5.5) (9.7) (10.9) Recognized net actuarial loss 0.3 0.4 0.7 0.8 Defined benefit settlement loss — 7.2 — 7.2 Net periodic cost $ 1.3 $ 7.9 $ 2.6 $ 8.6

Equity (Tables)

Equity (Tables)	6 Months Ended
	Mar. 31, 2024
Equity [Abstract]
Dividends Declared	Dividends Dividend activity in the six months ended March 31, 2024 are as follows: Date Declared Record Date Payable Date Amount Per Share August 1, 2023 September 7, 2023 October 4, 2023 $ 0.15 November 2, 2023 December 6, 2023 January 4, 2024 $ 0.15 February 1, 2024 March 7, 2024 April 4, 2024 $ 0.15

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Loss (Tables)	6 Months Ended
	Mar. 31, 2024
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Schedule of Changes in Accumulated Other Comprehensive Loss	The following table presents the changes in Accumulated Other Comprehensive (Loss) Income (“AOCI”), net of tax, by component: Foreign Pension and Hedging Total Balance as of October 1, 2023 $ (86.9) $ (86.0) $ 2.9 $ (170.0) Other comprehensive income (loss), net of tax 11.0 (1.2) 0.9 10.7 Reclassifications to earnings — 0.6 (1.6) (1.0) Balance as of March 31, 2024 $ (75.9) $ (86.6) $ 2.2 $ (160.3) Foreign Pension and Hedging Total Balance as of October 1, 2022 $ (131.2) $ (92.6) $ 7.7 $ (216.1) Other comprehensive income (loss), net of tax 60.1 (1.6) (4.0) 54.5 Reclassifications to earnings — 5.9 (4.0) 1.9 Balance as of March 31, 2023 $ (71.1) $ (88.3) $ (0.3) $ (159.7)
Schedule of Reclassifications out of Accumulated Other Comprehensive Loss	The following table presents the reclassifications out of AOCI: Three Months Ended Six Months Ended Affected Line Item in the Details of AOCI Components 2024 2023 2024 2023 Gain on cash flow hedges Foreign exchange contracts $ 0.8 $ 0.8 $ 2.4 $ 5.8 Other expense, net Income tax expense 0.3 0.2 0.8 1.8 Income tax provision 0.5 0.6 1.6 4.0 Amortization of defined benefit pension and postretirement items Actuarial losses (1) $ (0.3) $ (0.4) $ (0.7) $ (0.8) Defined benefit settlement loss — (7.2) — (7.2) Other expense, net Income tax (benefit) — (2.0) (0.1) (2.1) Income tax provision (0.3) (5.6) (0.6) (5.9) Total reclassifications for the period $ 0.2 $ (5.0) $ 1.0 $ (1.9) (1) These AOCI components are included in the computation of net periodic cost. See Note 9 of Notes to Condensed Consolidated Financial Statements.

Financial Instruments and Ris_2

Financial Instruments and Risk Management (Tables)	6 Months Ended
	Mar. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Fair Values of Derivative Instruments	The following table provides estimated fair values of derivative instruments: Fair Value of Assets (Liabilities) as of (1) March 31, September 30, Derivatives designated as cash flow hedging relationships: Foreign currency contracts $ 3.4 $ 4.4 Derivatives not designated as cash flow hedging relationships: Foreign currency contracts $ 0.1 $ 0.9 (1) Derivative assets are presented in Other current assets or Other assets. Derivative liabilities are presented in Other current liabilities or Other liabilities.
Schedule of Gains and Losses on Derivative Instruments	The following table provides the pre-tax amounts of gains and losses on derivative instruments: Three Months Ended Six Months Ended 2024 2023 2024 2023 Derivatives designated as cash flow hedging relationships: Foreign currency contracts Gain (loss) recognized in OCI (1) $ 4.8 $ 1.3 $ 1.5 $ (5.8) Gain reclassified from AOCI into income (1) (2) 0.8 0.9 2.4 5.8 Derivatives not designated as cash flow hedging relationships: Foreign currency contracts Gain (loss) recognized in income (2) $ 1.7 $ 2.4 $ 0.6 $ (0.3) (1) Each of these derivative instruments had a high correlation to the underlying exposure being hedged for the periods indicated and have been deemed highly effective by the Company in offsetting associated risk. (2)
Schedule of Offsetting Assets and Liabilities	The following table provides financial assets and liabilities for balance sheet offsetting: As of March 31, 2024 As of September 30, 2023 Assets (1) Liabilities (2) Assets (1) Liabilities (2) Foreign currency contracts Gross amounts of recognized assets (liabilities) $ 3.6 $ (1.2) $ 6.1 $ (0.7) Gross amounts offset in the balance sheet (0.2) — (0.2) 0.4 Net amounts of assets (liabilities) presented in the balance sheet $ 3.4 $ (1.2) $ 5.9 $ (0.3) (1) All derivative assets are presented in Other current assets or Other assets on the Condensed Consolidated Balance Sheets. (2) All derivative liabilities are presented in Other current liabilities or Other liabilities on the Condensed Consolidated Balance Sheets.
Schedule of Fair Value of Assets and Liabilities Measured on Recurring Basis	The following table sets forth the Company’s financial assets and liabilities, which are carried at fair value and measured on a recurring basis during the period, all of which are classified as Level 2 within the fair value hierarchy: March 31, September 30, Assets (Liabilities) at estimated fair value: Deferred compensation liability $ (20.5) $ (19.4) Derivatives - foreign currency contracts asset 2.2 5.6 Net assets (liabilities) at estimated fair value $ (18.3) $ (13.8)

Segment Data (Tables)

Segment Data (Tables)	6 Months Ended
	Mar. 31, 2024
Segment Reporting [Abstract]
Schedule of Segment Sales and Profitability	Segment net sales and profitability are presented below: Three Months Ended Six Months Ended 2024 2023 2024 2023 Net Sales Wet Shave $ 293.1 $ 308.6 $ 594.8 $ 583.9 Sun and Skin Care 235.8 209.7 351.2 322.6 Feminine Care 70.5 80.1 142.3 161.0 Total net sales $ 599.4 $ 598.4 $ 1,088.3 $ 1,067.5 Segment Profit Wet Shave $ 40.4 $ 35.4 $ 94.1 $ 71.1 Sun and Skin Care 54.4 40.0 53.1 53.3 Feminine Care 8.7 12.2 16.0 24.1 Total segment profit 103.5 87.6 163.2 148.5 General corporate and other expenses (15.0) (17.0) (31.2) (32.9) Amortization of intangibles (7.8) (7.7) (15.6) (15.4) Interest and other expense, net (23.1) (23.0) (43.2) (37.9) Restructuring and repositioning expenses (1) (3.2) (3.0) (10.0) (5.8) Acquisition and integration costs (2) (0.7) (2.0) (1.4) (4.1) Sun Care reformulation costs (3) (0.4) (0.6) (0.9) (1.1) Wet Ones manufacturing plant fire (4) (3.8) — (5.3) — Legal matter (5) (1.4) — (1.4) — Defined benefit settlement loss (6) — (7.2) — (7.2) Other project costs (7) (1.1) (0.5) (1.2) (0.5) Total earnings before income taxes $ 47.0 $ 26.6 $ 53.0 $ 43.6 (1) Includes pre-tax SG&A of nil and $0.1 for the three and six months ended March 31, 2023, respectively. Includes pre-tax Cost of products sold of $0.2 for the three and six months ended March 31, 2023, respectively. There were no amounts for pre-tax SG&A nor pre-tax Cost of products sold for the three and six months ended March 31, 2024. See Note 2 of the Notes to Condensed Consolidated Financial Statements. (2) Includes pre-tax SG&A of $0.7 and $1.4 for the three and six months ended March 31, 2024, respectively, for the acquisition of Billie, Inc. on November 29, 2021. Includes pre-tax SG&A of $2.0 and $4.1 for the three and six months ended March 31, 2023, respectively. (3) Includes pre-tax research and development costs of $0.4 and 0.9 for the three and six months ended March 31, 2024, respectively, and $0.6 and $1.1 for the three and six months ended March 31, 2023, respectively, related to the reformulation, recall and destruction of certain Sun Care products. (4) On December 1, 2023, a fire occurred at our Wet Ones manufacturing plant in Sidney, Ohio. There were no injuries reported and damage was limited to a single manufacturing process. As a consequence of the fire damage, there was a partial shutdown of the operations that manufacture Wet Ones raw materials. Through the three and six months ended March 31, 2024, the Company has incurred $3.8 and $5.3, respectively, in costs related to incremental material charges, labor and absorption as a result of the fire. (5) Includes pre-tax SG&A of $1.4 for both the three and six months ended March 31, 2024 related to the reserve for a legal matter. (6) Includes pre-tax loss of $7.2 for the three and six months ended March 31, 2023 related to the settlement of the Canada Plan. See Note 9 of the Notes to Condensed Consolidated Financial Statements. (7) Includes pre-tax SG&A of $1.1 and $1.2 for the three and six months ended March 31, 2024 and $0.5 and $0.5 for the three and six months ended March 31, 2023 related to certain corporate project costs.
Schedule of Sales by Geographic Area	The following table presents the Company’s net sales by geographic area: Three Months Ended Six Months Ended 2024 2023 2024 2023 Net Sales to Customers United States $ 355.1 $ 367.9 $ 609.3 $ 639.7 International 244.3 230.5 479.0 427.8 Total net sales $ 599.4 $ 598.4 $ 1,088.3 $ 1,067.5
Schedule of Supplemental Product Information	Supplemental product information is presented below for net sales: Three Months Ended Six Months Ended 2024 2023 2024 2023 Razors and blades $ 264.8 $ 278.4 $ 535.3 $ 525.4 Tampons, pads, and liners 70.5 80.1 142.3 161.0 Sun care products 175.0 153.8 226.0 201.6 Grooming products 45.0 38.0 91.8 85.3 Wipes and other skin care 15.8 17.9 33.4 35.7 Shaving gels and creams 28.3 30.2 59.5 58.5 Total net sales $ 599.4 $ 598.4 $ 1,088.3 $ 1,067.5

Background and Basis of Prese_2

Background and Basis of Presentation (Details)	3 Months Ended				6 Months Ended
	Mar. 31, 2024 USD ($) country $ / shares	Dec. 31, 2023 USD ($)	Mar. 31, 2023 USD ($) $ / shares	Dec. 31, 2022 USD ($)	Mar. 31, 2024 USD ($) country $ / shares	Mar. 31, 2023 USD ($) $ / shares	Sep. 30, 2023 USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of countries in which Edgewell operates | country	20				20
Number of countries with retail operations | country	50				50
Repayments of Revolving Credit Facility					$ 396,000,000	$ 392,000,000
Number of Reportable Segments | country	3
Cost of products sold	$ 341,300,000		$ 356,100,000		632,500,000	635,600,000
Segment profit	70,100,000		56,800,000		96,200,000	88,700,000
Earnings before income taxes	47,000,000		26,600,000		53,000,000	43,600,000
Income tax provision	11,000,000		7,200,000		12,200,000	11,800,000
Net earnings	$ 36,000,000	$ 4,800,000	$ 19,400,000	$ 12,400,000	$ 40,800,000	$ 31,800,000
Basic net earnings per share | $ / shares	$ 0.72		$ 0.38		$ 0.82	$ 0.62
Diluted net earnings per share | $ / shares	$ 0.72		$ 0.37		$ 0.81	$ 0.61
Gross Profit	$ 258,100,000		$ 242,300,000		$ 455,800,000	$ 431,900,000
Net sales	599,400,000		598,400,000		1,088,300,000	1,067,500,000
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	22,200,000		36,200,000		50,500,000	88,200,000
Supplier Finance Program, Obligation	22.8				22.8		$ 21.8
Accounts Payable, Current	$ (219,700,000)				(219,700,000)		(194,400,000)
Other, net					$ (36,100,000)	(72,000,000)
Restatement Adjustment
Cost of products sold			(600,000)			(1,200,000)
Segment profit			600,000			1,200,000
Earnings before income taxes			600,000			1,200,000
Income tax provision			200,000			300,000
Net earnings			$ 400,000			$ 900,000
Basic net earnings per share | $ / shares			$ 0.01			$ 0.02
Diluted net earnings per share | $ / shares			$ 0			$ 0.01
Gross Profit			$ 600,000			$ 1,200,000
Comprehensive Income (Loss), Net of Tax, Attributable to Parent			400,000			900,000
Accounts Payable, Current							$ 8,500,000
Other, net						(900,000)
Previously Reported
Cost of products sold			356,700,000			636,800,000
Segment profit			56,200,000			87,500,000
Earnings before income taxes			26,000,000			42,400,000
Income tax provision			7,000,000			11,500,000
Net earnings			$ 19,000,000			$ 30,900,000
Basic net earnings per share | $ / shares			$ 0.37			$ 0.60
Diluted net earnings per share | $ / shares			$ 0.37			$ 0.60
Gross Profit			$ 241,700,000			$ 430,700,000
Comprehensive Income (Loss), Net of Tax, Attributable to Parent			$ 35,800,000			87,300,000
Other, net						$ (71,100,000)

Restructuring Charges (Schedule

Restructuring Charges (Schedule of Charges Related to Restructuring Activities) (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023	Sep. 30, 2023
Restructuring Cost and Reserve [Line Items]
Severance Costs	$ 1.1	$ 1.9	$ 5	$ 2.8
Other Restructuring Costs	1.9	1.1	4.7	3
Restructuring and related costs	3.2	3.2	10	6
Restructuring Reserve	2.1		2.1		$ 4.6
Asset Impairment and Accelerated Depreciation	$ 0.2	0.2	$ 0.3	0.2
Restructuring Charges, including amounts included in Cost of Products Sold		0.2		0.2
Restructuring Charges, Including Amounts in Selling, General and Administrative Expenses		$ 0		0.1
Selling, general and administrative expenses
Restructuring Cost and Reserve [Line Items]
Restructuring Charges, Including Amounts in Selling, General and Administrative Expenses				$ 0.1

Restructuring Charges (Schedu_2

Restructuring Charges (Schedule of Restructuring Activities and Related Accruals) (Details) - USD ($)	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Restructuring Reserve [Roll Forward]
Beginning Balance			$ 4,600,000
Restructuring and related costs	$ 3,200,000	$ 3,200,000	10,000,000	$ 6,000,000
Utilized - Cash Payments			(12,500,000)
Ending Balance	2,100,000		2,100,000
Restructuring and Related Cost, Expected Cost	19		19
Restructuring Charges, including amounts included in Cost of Products Sold		$ 200,000		$ 200,000
Employee Severance [Member]
Restructuring Reserve [Roll Forward]
Beginning Balance			3,900,000
Restructuring and related costs			5,300,000
Utilized - Cash Payments			(7,100,000)
Ending Balance	2,100,000		2,100,000
Other Restructuring [Member]
Restructuring Reserve [Roll Forward]
Beginning Balance			700,000
Restructuring and related costs			4,700,000
Utilized - Cash Payments			(5,400,000)
Ending Balance	$ 0		$ 0

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Income Tax Disclosure [Abstract]
Income tax provision	$ 11	$ 7.2	$ 12.2	$ 11.8
Earnings before income taxes	$ 47	$ 26.6	$ 53	$ 43.6
Effective tax rate	23.40%	27%	23%	26.90%

Earnings per Share (Schedule of

Earnings per Share (Schedule of Weighted-Average Shares Outstanding) (Details) - shares shares in Millions	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Schedule Of Weighted Average Number Of Shares [Line Items]
Basic weighted-average shares outstanding (in shares)	49.8	51.4	50	51.5
Effect of dilutive securities (in shares)	0.4	0.6	0.3	0.5
Diluted weighted-average shares outstanding (in shares)	50.2	52	50.3	52
Share options
Schedule Of Weighted Average Number Of Shares [Line Items]
Anti-dilutive awards excluded from the calculation of diluted weighted-average shares outstanding (in shares)	1.1	0.8	1.1	1
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive awards excluded from the calculation of diluted weighted-average shares outstanding (in shares)	1.1	0.8	1.1	1
RSE and PRSE awards
Schedule Of Weighted Average Number Of Shares [Line Items]
Anti-dilutive awards excluded from the calculation of diluted weighted-average shares outstanding (in shares)	0.3	0	0.5	0.2
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive awards excluded from the calculation of diluted weighted-average shares outstanding (in shares)	0.3	0	0.5	0.2
RSE and PRSE awards
Schedule Of Weighted Average Number Of Shares [Line Items]
Effect of dilutive securities (in shares)	0.4	0.6	0.3	0.5

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets (Schedule of Goodwill) (Details) - USD ($) $ in Millions	6 Months Ended
	Mar. 31, 2024	Sep. 30, 2023
Goodwill [Line Items]
Goodwill, Gross	$ 1,704.9	$ 1,702.4
Accumulated goodwill impairment loss	371	371
Goodwill [Roll Forward]
Beginning balance	1,331.4
Cumulative translation adjustment	(2.5)
Ending balance	1,333.9
Wet Shave
Goodwill [Line Items]
Goodwill, Gross	1,142.4	1,140.5
Accumulated goodwill impairment loss	369	369
Goodwill [Roll Forward]
Beginning balance	771.5
Cumulative translation adjustment	(1.9)
Ending balance	773.4
Sun and Skin Care
Goodwill [Line Items]
Goodwill, Gross	356.4	355.9
Accumulated goodwill impairment loss	2	2
Goodwill [Roll Forward]
Beginning balance	353.9
Cumulative translation adjustment	(0.5)
Ending balance	354.4
Feminine Care
Goodwill [Line Items]
Goodwill, Gross	206.1	206
Accumulated goodwill impairment loss	0	$ 0
Goodwill [Roll Forward]
Beginning balance	206
Cumulative translation adjustment	(0.1)
Ending balance	$ 206.1

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets (Schedule of Amortizable Intangible Assets) (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023	Sep. 30, 2023
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross carrying amount	$ 690.2		$ 690.2		$ 688.8
Amortizable intangible assets, accumulated amortization	324.4		324.4		307.9
Amortizable intangible assets, net	365.8		365.8		380.9
Other intangible assets, net	960.4		960.4		973.8
Intangible Assets, Gross (Excluding Goodwill)	1,284.8		1,284.8		1,281.7
Amortization of intangibles	7.8	$ 7.7	15.6	$ 15.4
Amortizable intangible assets, amortization expense, remainder of 2023	15.5		15.5
Amortizable intangible assets, amortization expense, fiscal 2024	31.1		31.1
Amortizable intangible assets, amortization expense, fiscal 2025	30.7		30.7
Amortizable intangible assets, amortization expense, fiscal 2026	30.5		30.5
Amortizable intangible assets, amortization expense, fiscal 2027	30.4		30.4
Amortizable intangible assets, amortization expense, fiscal 2028	30.4		30.4
Amortizable intangible assets, amortization expense, after fiscal 2028	197.2		197.2
Indefinite-lived intangible assets	594.6		594.6		592.9
Trade names and brands
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross carrying amount	339.6		339.6		339.6
Amortizable intangible assets, accumulated amortization	96.1		96.1		88.1
Amortizable intangible assets, net	243.5		243.5		251.5
Technology and patents
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross carrying amount	79.6		79.6		79.4
Amortizable intangible assets, accumulated amortization	76.7		76.7		76.2
Amortizable intangible assets, net	2.9		2.9		3.2
Customer related and other
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross carrying amount	271		271		269.8
Amortizable intangible assets, accumulated amortization	151.6		151.6		143.6
Amortizable intangible assets, net	$ 119.4		$ 119.4		$ 126.2

Supplemental Balance Sheet In_3

Supplemental Balance Sheet Information (Details) - USD ($) $ in Millions	Mar. 31, 2024	Sep. 30, 2023
Inventories
Raw materials and supplies	$ 87.3	$ 86.3
Work in process	95.8	91.1
Finished products	313.3	315
Total inventories	496.4	492.4
Other Current Assets
Prepaid expenses	78.8	72.5
Value added tax receivables	60.2	43.7
Income taxes receivable	18.5	18.9
Other	14.1	12.3
Total other current assets	171.6	147.4
Property, Plant and Equipment
Land	18.6	18.5
Buildings	144.3	142.6
Machinery and equipment	1,118.7	1,105.3
Capitalized software costs	61.6	60.2
Construction in progress	41.4	38.5
Total gross property, plant and equipment	1,384.6	1,365.1
Accumulated depreciation and amortization	(1,057.1)	(1,027.2)
Total property, plant and equipment, net	327.5	337.9
Other Current Liabilities
Accrued advertising and sales promotion	44.7	31.5
Accrued trade allowances	28.3	29.8
Accrued salaries, vacations and incentive compensation	42.8	65.4
Income taxes payable	8.6	11.9
Returns reserve	33.6	53.5
Value added tax payable	26.5	7
Accrued interest	25.2	25
Other	88.9	85.4
Total other current liabilities	298.6	309.5
Other Liabilities
Pensions and other retirement benefits	60.7	58.2
Other	115.5	121.5
Total other liabilities	$ 176.2	$ 179.7

Accounts Receivable Facility (N

Accounts Receivable Facility (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023	Sep. 30, 2023
Accounts receivable sales agreement
Transfer of Financial Assets Accounted for as Sales [Line Items]
Loss on sale of accounts receivable	$ 1.6	$ 1.5	$ 2.8	$ 2.4
Accounts receivable sales agreement
Transfer of Financial Assets Accounted for as Sales [Line Items]
Accounts receivable sold through AR Facility	316.4	$ 315.5	532.5	$ 527.6
Transfer of accounts receivable, sales amount derecognized	$ 119.3		$ 119.3		$ 82.1

Debt (Details)

Debt (Details) - USD ($)	3 Months Ended			6 Months Ended
	Mar. 31, 2024		Mar. 31, 2023	Mar. 31, 2023	Apr. 02, 2024	Sep. 30, 2023
Debt Instrument [Line Items]
Total	$ 1,361,000,000					$ 1,372,000,000
Long-term debt	1,350,800,000					1,360,700,000
Notes payable	23,600,000					19,500,000
Unamortized debt issuance costs	$ 10,200,000	[1]				$ 11,300,000
Short-Term Debt, Weighted Average Interest Rate, at Point in Time	3.80%					3.90%
Defined benefit settlement loss				$ (7,200,000)
Pension Plan
Debt Instrument [Line Items]
Defined benefit settlement loss	$ 7,200,000		$ 7,200,000	$ 7,200,000
2024 Revolving Credit Facility [Member] | Subsequent Event
Debt Instrument [Line Items]
Line of Credit, Current					$ 425,000,000
Senior notes | Senior Notes, Due 2028
Debt Instrument [Line Items]
Total	750,000,000					$ 750,000,000
Unamortized debt issuance costs	$ 6,200,000					6,900,000
Long term debt, stated interest rate	5.50%
Minimum Debt amount	$ 150
Senior notes | Senior Notes, Due 2029
Debt Instrument [Line Items]
Total	500,000,000					500,000,000
Unamortized debt issuance costs	$ 4,000,000					4,400,000
Long term debt, stated interest rate	4.125%
Minimum Debt amount	$ 150
Revolving credit facility
Debt Instrument [Line Items]
Total	$ 111,000,000					$ 122,000,000
[1] As of March 31, 2024, debt issuance costs were $6.2 and $4.0 related to the Senior Notes due 2028 and the Senior Notes due 2029, respectively. As of September 30, 2023, debt issuance costs were $6.9 and $4.4 related to the Senior Notes due 2028 and the Senior Notes due 2029, respectively.

Retirement Plans (Details)

Retirement Plans (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Retirement Benefits [Abstract]
Service cost	$ 0.4	$ 0.4	$ 0.9	$ 0.9
Interest cost	5.4	5.4	10.7	10.6
Expected return on plan assets	(4.8)	(5.5)	(9.7)	(10.9)
Recognized net actuarial loss	0.3	0.4	0.7	0.8
Net periodic cost	$ 1.3	$ 7.9	$ 2.6	8.6
Defined benefit settlement loss				$ (7.2)

Equity (Details)

Equity (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions		3 Months Ended					6 Months Ended
	May 08, 2024	Mar. 31, 2024	Dec. 31, 2023	Sep. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2024	Mar. 31, 2023	Jan. 26, 2018
Equity [Abstract]
Share repurchase authorization									10
Treasury shares repurchased (in shares)							0.8
Treasury shares repurchased (in usd)		$ 15.4	$ 15.5		$ 15	$ 15
Share repurchase authorization, remaining		3.8					3.8
Dividends declared							$ 15.2
Dividends to common shareholders							15.8	$ 16.1
Dividends declared (per share)		$ 0.15	$ 0.15	$ 0.15
Dividends declared (per share)		$ 0.15	$ 0.15	$ 0.15
us-gaap_TreasuryStockValueAcquiredCostMethodlessexcisetax							$ 30.3
Subsequent Event
Equity [Abstract]
Dividends declared (per share)	$ 0.15
Dividends declared (per share)	$ 0.15

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Loss (Schedule of Accumulated Other Comprehensive Loss) (Details) - USD ($) $ in Millions	6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	$ (170)	$ (216.1)
OCI before reclassifications	10.7	54.5
Reclassifications to earnings	(1)	1.9
Ending balance	(160.3)	(159.7)
Foreign Currency Translation Adjustments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(86.9)	(131.2)
OCI before reclassifications	11	60.1
Reclassifications to earnings	0	0
Ending balance	(75.9)	(71.1)
Pension and Post-retirement Activity
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(86)	(92.6)
OCI before reclassifications	(1.2)	(1.6)
Reclassifications to earnings	0.6	5.9
Ending balance	(86.6)	(88.3)
Hedging Activity
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	2.9	7.7
OCI before reclassifications	0.9	(4)
Reclassifications to earnings	(1.6)	(4)
Ending balance	$ 2.2	$ (0.3)

Accumulated Other Comprehensi_4

Accumulated Other Comprehensive Loss (Schedule of Reclassifications out of Accumulated Other Comprehensive Loss) (Details) - USD ($) $ in Millions	3 Months Ended				6 Months Ended
	Mar. 31, 2024		Mar. 31, 2023		Mar. 31, 2024	Mar. 31, 2023
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassifications to earnings					$ 1	$ (1.9)
Reclassification out of Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
OCI Cash flow hedges reclass to earnings, before tax	$ 0.8		$ 0.8
OCI Cash flow hedge, reclassification to earnings, tax	0.3		0.2		0.8	1.8
Other comprehensive income, reclassification to earnings, cash flow hedges, after tax	0.5		0.6		1.6	4
Amortization of defined benefit pension and postretirement items, actuarial losses, before tax	(0.3)	[1]	(0.4)	[1]	(0.7)	(0.8)
Amortization of defined benefit pension and postretirement items, tax	0		(2)		(0.1)	(2.1)
Amortization of defined benefit pension and postretirement items, after tax	(0.3)		(5.6)		(0.6)	(5.9)
Reclassifications to earnings	$ 0.2		$ (5)		$ 1	$ (1.9)
[1] These AOCI components are included in the computation of net periodic cost. See Note 9 of Notes to Condensed Consolidated Financial Statements.

Financial Instruments and Ris_3

Financial Instruments and Risk Management (Narrative) (Details) $ in Millions	3 Months Ended			6 Months Ended
	Mar. 31, 2024 USD ($) contracts	Dec. 31, 2023 USD ($)	Mar. 31, 2023	Mar. 31, 2024 USD ($) contracts	Mar. 31, 2023	Sep. 30, 2023 USD ($)
Derivative [Line Items]
Long-term debt	$ 1,361			$ 1,361		$ 1,372
Fixed rate
Derivative [Line Items]
Long-term debt	1,250			1,250		1,250
Fair value of long-term debt	$ 1,127.9			$ 1,127.9		$ 1,028.6
Not designated as hedge | FX contract
Derivative [Line Items]
Open foreign currency contracts | contracts	2			2
Derivative, notional amount	$ 9			$ 9
Not designated as hedge | FX contract | Other expense (income), net
Derivative [Line Items]
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]
Cash flow hedge | Designated as hedge | FX contract
Derivative [Line Items]
Open foreign currency contracts | contracts	64			64
Derivative, notional amount	$ 108.1			$ 108.1
Gain (loss) recognized in OCI		$ 4.4		$ 3.4

Financial Instruments and Ris_4

Financial Instruments and Risk Management (Schedule of Fair Values of Derivative Instruments) (Details) - FX contract - USD ($) $ in Millions		Mar. 31, 2024	Sep. 30, 2023
Not designated as hedge
Derivatives, Fair Value [Line Items]
Estimated fair value of derivatives	[1]	$ 0.1	$ 0.9
Cash flow hedge | Designated as hedge
Derivatives, Fair Value [Line Items]
Estimated fair value of derivatives	[1]	$ 3.4	$ 4.4
[1]erivative assets are presented in Other current assets or Other assets. Derivative liabilities are presented in Other current liabilities or Other liabilities.

Financial Instruments and Ris_5

Financial Instruments and Risk Management (Schedule of Gains and Losses on Derivative Instruments) (Details) - USD ($) $ in Millions	3 Months Ended			6 Months Ended
	Mar. 31, 2024	Dec. 31, 2023	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]	Nonoperating Income (Expense)		Nonoperating Income (Expense)	Nonoperating Income (Expense)	Nonoperating Income (Expense)
FX contract | Designated as hedge | Cash flow hedge
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in OCI		$ 4.4		$ 3.4
Unrealized Gain (Loss) on Interest Rate Cash Flow Hedges, Pretax, Accumulated Other Comprehensive Income (Loss)	$ 4.8		$ 1.3	$ 1.5	$ (5.8)
FX contract | Not designated as hedge | Other expense (income), net
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]

Financial Instruments and Ris_6

Financial Instruments and Risk Management (Schedule of Offsetting Assets and Liabilities) (Details) - FX contract - USD ($) $ in Millions	Mar. 31, 2024	Sep. 30, 2023
Derivative [Line Items]
Gross amounts of recognized assets	$ 3.6	$ 6.1
Gross amounts of recognized liabilities	(1.2)	(0.7)
Gross amounts offset in the balance sheet	(0.2)	(0.2)
Gross amounts offset in the balance sheet	0	0.4
Net amounts of assets presented in the balance sheet	3.4	5.9
Net amounts of liabilities presented in the balance sheet	$ (1.2)	$ (0.3)

Financial Instruments and Ris_7

Financial Instruments and Risk Management (Schedule of Fair Value of Assets and Liabilities Measured on Recurring Basis) (Details) - Recurring fair value measurement - Level 2 - USD ($) $ in Millions	Mar. 31, 2024	Sep. 30, 2023
Derivative [Line Items]
Deferred compensation liability	$ (20.5)	$ (19.4)
Derivatives - foreign currency contracts asset	2.2	5.6
Net assets (liabilities) at estimated fair value	$ (18.3)	$ (13.8)

Segment Data (Schedule of Segme

Segment Data (Schedule of Segment Sales and Profitability) (Details) - USD ($)	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Segment Reporting Information [Line Items]
Net sales	$ 599,400,000	$ 598,400,000	$ 1,088,300,000	$ 1,067,500,000
Segment profit	70,100,000	56,800,000	96,200,000	88,700,000
Acquisition and integration costs	(700,000)	(2,000,000)	(1,400,000)	(4,100,000)
Sun Care reformulation costs	(400,000)	(600,000)	(900,000)	(1,100,000)
Wet Ones manufacturing plant fire	(3,800,000)	0	(5,300,000)	0
Loss Contingency, Damages Sought, Value	(1,400,000)		(1,400,000)
Other project costs	(1,100,000)	(500,000)	(1,200,000)	(500,000)
General corporate and other expenses	(7,800,000)	(7,700,000)	(15,600,000)	(15,400,000)
Amortization of intangibles	(23,100,000)	(23,000,000)	(43,200,000)	(37,900,000)
Earnings before income taxes	47,000,000	26,600,000	53,000,000	43,600,000
Pension settlement expense		7,200,000		7,200,000
Restructuring Charges, including amounts included in Cost of Products Sold		200,000		200,000
Restructuring Charges, Including Amounts in Selling, General and Administrative Expenses		0		100,000
Restructuring Charges	(3,200,000)	(3,000,000)	(10,000,000)	(5,700,000)
Restructuring charges, including amounts in COGS				(5,800,000)
Wet Shave
Segment Reporting Information [Line Items]
Net sales	293,100,000	308,600,000	594,800,000	583,900,000
Segment profit	40,400,000	35,400,000	94,100,000	71,100,000
Sun and Skin Care
Segment Reporting Information [Line Items]
Net sales	235,800,000	209,700,000	351,200,000	322,600,000
Segment profit	54,400,000	40,000,000	53,100,000	53,300,000
Feminine Care
Segment Reporting Information [Line Items]
Net sales	70,500,000	80,100,000	142,300,000	161,000,000
Segment profit	8,700,000	12,200,000	16,000,000	24,100,000
Total Segments
Segment Reporting Information [Line Items]
Segment profit	103,500,000	87,600,000	163,200,000	148,500,000
Corporate
Segment Reporting Information [Line Items]
General Corporate and Other Expenses	(15,000,000)	(17,000,000)	(31,200,000)	(32,900,000)
Selling, general and administrative expenses
Segment Reporting Information [Line Items]
Acquisition and integration costs	(700,000)	(2,000,000)	(1,400,000)	(4,100,000)
Other project costs	$ (1,100,000)	(500,000)	$ (1,200,000)	(500,000)
Pension settlement expense				7.2
Restructuring Charges, Including Amounts in Selling, General and Administrative Expenses				100,000
Cost of products sold
Segment Reporting Information [Line Items]
Restructuring Charges, including amounts included in Cost of Products Sold		$ 200,000		$ 200,000

Segment Data Segment Data (Sche

Segment Data Segment Data (Schedule of Sales by Geographical Area) (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Revenue from External Customer [Line Items]
Net sales	$ 599.4	$ 598.4	$ 1,088.3	$ 1,067.5
United States
Revenue from External Customer [Line Items]
Net sales	355.1	367.9	609.3	639.7
International
Revenue from External Customer [Line Items]
Net sales	$ 244.3	$ 230.5	$ 479	$ 427.8

Segment Data (Schedule of Suppl

Segment Data (Schedule of Supplemental Product Information) (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Revenue from External Customer [Line Items]
Net sales	$ 599.4	$ 598.4	$ 1,088.3	$ 1,067.5
Razors and blades
Revenue from External Customer [Line Items]
Net sales	264.8	278.4	535.3	525.4
Tampons, pads and liners
Revenue from External Customer [Line Items]
Net sales	70.5	80.1	142.3	161
Sun care products
Revenue from External Customer [Line Items]
Net sales	175	153.8	226	201.6
Grooming products
Revenue from External Customer [Line Items]
Net sales	45	38	91.8	85.3
Wipes and other skin care products
Revenue from External Customer [Line Items]
Net sales	15.8	17.9	33.4	35.7
Shaving gels and creams
Revenue from External Customer [Line Items]
Net sales	$ 28.3	$ 30.2	$ 59.5	$ 58.5

Commitment and Contingencies (D

Commitment and Contingencies (Details)	3 Months Ended
	Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure	Commitments and Contingencies Legal Proceedings The Company and its subsidiaries are subject to a number of legal proceedings in various jurisdictions arising out of its operations during the ordinary course of business. Many of these legal matters are in preliminary stages and involve complex issues of law and fact and may proceed for protracted periods of time. The amount of liability, if any, from these proceedings cannot be determined with certainty. The Company reviews its legal proceedings and claims, regulatory reviews and inspections and other legal proceedings on an ongoing basis and follows appropriate accounting guidance when making accrual and disclosure decisions. The Company establishes accruals for those contingencies when the incurrence of a loss is probable and can be reasonably estimated and discloses the amount accrued and the amount of a reasonably possible loss in excess of the amount accrued if such disclosure is necessary for its financial statements to not be misleading. The Company does not record liabilities when the likelihood that the liability has been incurred is probable, but the amount cannot be reasonably estimated. Based upon present information, the Company believes that its liability, if any, arising from such pending legal proceedings, asserted legal claims, and known potential legal claims which are likely to be asserted, is not reasonably likely to be material to its financial position, results of operations or cash flows, when taking into account established accruals for estimated liabilities.